A new study published in the Journal of Urology has found that activation of the body’s CB2 receptors has the potential to treat bladder pain and inflammation, and can increase bladder urinary frequency.
For the study, researchers at the University of Wisconsin-Madison used mouse models to examine whether or not activation of CB2 receptors (something which cannabis does naturally) can treat serious bladder issues; the results were quite clear that it does.
Here is the study conclusion:
Treatment with a selective CB2 agonist reduced severity of established acrolein-induced cystitis and inhibited bladder inflammation-associated increased referred mechanical sensitivity and increased bladder urinary frequency. Our data indicate that CB2 receptor is a potential therapeutic target for treatment of painful inflammatory bladder diseases.
Note: an agonist enhances activity. An antagonist reduces activity.